Having trouble viewing this email? View in your browser.
ESCMID Logo

2 August 2016
WEEKLY NEWS

Dear colleagues,

The society published a press release on a study in its journal Clinical Microbiology and Infection, showing that significantly more women than men diagnosed with Staphylococcus aureus bacteraemia (SAB) die within 30 days.

Best regards, your ESCMID communications editors

 

ECDC guidelines on prudent antimicrobial use is open for consultation

The ECDC encourages the scientific community and stakeholders to comment on the draft guidelines on the prudent use of antimicrobials in a public consultation, which will be open until 5 September 2016. You may also find a relevant news item here and the draft guideline document here.

In view of the rising threat from resistance due to antimicrobial misuse and overuse the European Commission has asked ECDC to develop guidelines on their prudent use. The final guideline document will include generic principles of good practice on the appropriate use of antimicrobial agents in human medical practice in the European Union.

› Read more
 

CMI highlight: evolution of hepatitis B infection incidence in France

Researchers in Lyon studied the incidence and prevalence of hepatitis B virus (HBV) infection in a large sentinel cohort to evaluate the epidemiology of HBV during vaccination policy changes. The HBV incidence fluctuated between 5 and 8 per 1,000 person-years in pre-1986 birth-cohorts, decreased to 2.1 in birth-cohorts 1986 to 1991 and rebounded to 5 in post-1991 birth-cohorts. The authors of the study concluded that the HBV incidence was ‘remarkably high’ in young adults with noticeable variations concomitantly to vaccination policy changes. A dramatic decline in immunization rate was temporally associated with a sharp rebound of infection after withdrawal of systematic adolescent vaccination in 1998, the researchers wrote in their paper published in CMI

› Read more
 

Use the summer break to apply for a 2017 research grant!

Applications for next year’s ESCMID research grants are being accepted until 13 October 2016 at 12:00 noon CET. For the 2017 grants we only accept proposals for projects dealing with fungal/viral/parasitic infections and diseases (including diagnostics, pathogenesis, susceptibility, resistance, stewardship and vaccines). This focus increases the chances of the individual projects. In addition to the regular grants worth EUR 20,000, ESCMID has reserved up to EUR 50,000 each for two excellently rated projects.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.